Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risks and benefits of reducing the number of drugs to treat HIV-1 infection.
Cadiñanos J, Montejano R, de Miguel Buckley R, Marcelo C, Arribas JR. Cadiñanos J, et al. Among authors: montejano r. Expert Opin Drug Saf. 2021 Apr;20(4):397-409. doi: 10.1080/14740338.2021.1887135. Epub 2021 Feb 24. Expert Opin Drug Saf. 2021. PMID: 33557651 Review.
Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid.
Stella-Ascariz N, Montejano R, Martin-Vicente M, Mingorance J, Pérez-Valero I, Bernardino JI, Arribas JR. Stella-Ascariz N, et al. Among authors: montejano r. Open Forum Infect Dis. 2016 Feb 19;3(1):ofw041. doi: 10.1093/ofid/ofw041. eCollection 2016 Jan. Open Forum Infect Dis. 2016. PMID: 27006965 Free PMC article.
Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients.
Montejano R, Stella-Ascariz N, Monge S, Bernardino JI, Pérez-Valero I, Montes ML, Valencia E, Martín-Carbonero L, Moreno V, González-García J, Arnalich F, Mingorance J, Pintado Berniches L, Perona R, Arribas JR. Montejano R, et al. J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):102-109. doi: 10.1097/QAI.0000000000001391. J Acquir Immune Defic Syndr. 2017. PMID: 28418989 Free article.
A safety evaluation of raltegravir for the treatment of HIV.
de Miguel R, Montejano R, Stella-Ascariz N, Arribas JR. de Miguel R, et al. Among authors: montejano r. Expert Opin Drug Saf. 2018 Feb;17(2):217-223. doi: 10.1080/14740338.2018.1411903. Epub 2017 Dec 5. Expert Opin Drug Saf. 2018. PMID: 29199485 Review.
New Strategies of ARV: the Road to Simplification.
de Miguel Buckley R, Montejano R, Stella-Ascariz N, Arribas JR. de Miguel Buckley R, et al. Among authors: montejano r. Curr HIV/AIDS Rep. 2018 Feb;15(1):11-19. doi: 10.1007/s11904-018-0371-6. Curr HIV/AIDS Rep. 2018. PMID: 29353398 Review.
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
Troya J, Montejano R, Ryan P, Gómez C, Matarranz M, Cabello A, Vera F, Sepúlveda MA, Santos I, Samperiz G, Bachiller P, Boix V, Barrufet P, Cervero M, Sanz J, Solís J, Yllescas M, Valencia E; GESIDA-8715 Study Group. Troya J, et al. Among authors: montejano r. PLoS One. 2018 Jun 14;13(6):e0198768. doi: 10.1371/journal.pone.0198768. eCollection 2018. PLoS One. 2018. PMID: 29902204 Free PMC article.
Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-Infected Adults.
Montejano R, Stella-Ascariz N, Monge S, Bernardino JI, Pérez-Valero I, Montes ML, Valencia E, Martín-Carbonero L, Moreno V, González-Garcia J, Rodriguez-Centeno J, Rodes B, Cantos AE, Alejos B, de Miguel R, Arnalich F, Perona R, Arribas JR. Montejano R, et al. J Infect Dis. 2018 Oct 5;218(10):1531-1540. doi: 10.1093/infdis/jiy364. J Infect Dis. 2018. PMID: 29912427
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1.
Stella-Ascariz N, Montejano R, Rodriguez-Centeno J, Alejos B, Schwimmer C, Bernardino JI, Rodes B, Allavena C, Hoffmann C, Gisslén M, de Miguel R, Esteban-Cantos A, Wallet C, Raffi F, Arribas JR; NEAT 001/ ANRS 143 Study Group. Stella-Ascariz N, et al. Among authors: montejano r. J Infect Dis. 2018 Oct 5;218(10):1523-1530. doi: 10.1093/infdis/jiy399. J Infect Dis. 2018. PMID: 29982509
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Davey RT Jr, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD; INSIGHT FLU-IVIG Study Group. Davey RT Jr, et al. Lancet Respir Med. 2019 Nov;7(11):951-963. doi: 10.1016/S2213-2600(19)30253-X. Epub 2019 Sep 30. Lancet Respir Med. 2019. PMID: 31582358 Free PMC article. Clinical Trial.
77 results